Head and Neck Cancer

MO 17 - Head and Neck 2- Head & Neck Research Update

Moderator(s)

• ND

  Neal Dunlap, MD

  University of Louisville
• MM

  Michelle Mierzwa, MD

  University of Michigan

Presentations:

• 4:45 PM - 4:50 PM

  Immuno-Radiotherapy with Cetuximab and Avelumab for Advanced Stage Head and Neck Squamous Cell Carcinoma: Results from a Phase-IB Trial
  Presenter: Jos Elbers, MD – Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL)
  Presentation No : 1204
• 4:50 PM - 4:55 PM

  A Randomized Phase II Translational Research Study in Patients with Advanced Head and Neck Cancer to Investigate the Effects of Standard Chemoradiation and Add-on Concurrent Epidermal Growth Factor Receptor (EGFR) Inhibitor ? Consolidation EGFR Inhibitor
  Presenter: Oliver Riesterer, MD – Canton Hospital Aarau
  Presentation No : 1205
• 4:55 PM - 5:00 PM

  Predictors of Early Response to Immunotherapy in Head and Neck Cancer: A Secondary Clinical and Radiomic Analysis of a Prospective Randomized Trial with Nivolumab
  Presenter: Yao Yu, MD – Memorial Sloan Kettering Cancer Center
  Presentation No : 1206
• 5:00 PM - 5:05 PM

  Correlative Analyses between Tissue-Based Hypoxia Biomarkers and Hypoxia PET Imaging in Head and Neck Cancer Patients during Radiochemotherapy: Results from a Prospective Trial
  Presenter: Nils Nicolay, MD, PhD – University of Freiburg
  Presentation No : 1207
• 5:05 PM - 5:10 PM

  Discussant
  Discussant: Upendra Parvathaneni, MD, FRANZCR – University of Washington
  
• 5:10 PM - 5:15 PM

  A Multicenter Prospective Observational Study of Nutritional Status in Locally Advanced Nasopharynx Cancer Treated by Induction Chemotherapy and Chemoradiotherapy
  Presenter: Jingjing Miao, MS – Sun Yat-Sen University Cancer Center
  Presentation No : 1208
• 5:20 PM - 5:25 PM

  Radiation-Induced Hypoglossal Nerve Palsy after Definitive Radiotherapy for Nasopharyngeal Carcinoma: Clinical Predictors and Dose-Toxicity Relationship
  Presenter: James Chung-Hang Chow, MBChB(Hons), FRCR – Queen Elizabeth Hospital
  Presentation No : 1210
• 5:25 PM - 5:30 PM

  Prospective Phase II Study of Concurrent Chemoradiotherapy in High-risk Malignant Salivary Gland Tumors
  Presenter: jin dou, MD – Fudan University Shanghai Cancer Center
  Presentation No : 1212
• 5:30 PM - 5:35 PM

  Characterization and Prediction of Opioid Use in Head and Neck Cancer Patients Undergoing Local Therapy
  Presenter: Paul Riviere, BS – UCSD Radiation Medicine and Applied Sciences
  Presentation No : 1213
• 5:35 PM - 5:40 PM

  Difference in Outcomes for Patients with HPV Type 16 Versus HPV Non-Type 16 Oropharyngeal Squamous Cell Carcinoma
  Presenter: Rachel Shenker, MD – Wake Forest University Medical Center
  Presentation No : 1214
• 5:40 PM - 5:45 PM

  PIK3CA Mutation Is an Adverse Prognostic Factor in HPV-Associated Oropharynx Cancer
  Presenter: Brian Beaty, MD, PhD – University of North Carolina Hospitals
  Presentation No : 1215
• 5:45 PM - 5:50 PM

  Long Term Toxicity and Oncologic Outcomes of De-Intensified Chemoradiation in Early Stage Oropharyngeal Carcinoma
  Presenter: Matthew Deek, MD – Johns Hopkins University
  Presentation No : 1216